Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
PKM2-mediated collagen XVII expression is critical for wound repair
Yangdan Liu, … , Yifan Zhang, Ya Gao
Yangdan Liu, … , Yifan Zhang, Ya Gao
Published January 22, 2025
Citation Information: JCI Insight. 2025;10(4):e184457. https://doi.org/10.1172/jci.insight.184457.
View: Text | PDF
Research Article Dermatology Therapeutics

PKM2-mediated collagen XVII expression is critical for wound repair

  • Text
  • PDF
Abstract

Chronic wounds have emerged as a tough clinical challenge. An improved understanding of wound-healing mechanisms is paramount. Collagen XVII (COL17), a pivotal constituent of hemidesmosomes, holds considerable promise for regulating epidermal cell adhesion to the basement membrane as well as for epidermal cell motility and self-renewal of epidermal stem cells. However, the precise role of COL17 in wound repair remains elusive, and the upstream regulatory mechanisms involved have not been fully elucidated. In this study, we delineated the temporal and spatial expression patterns of COL17 at the epidermal wound edge. Subsequently, we investigated the indispensable role of COL17 in keratinocyte activation and reepithelialization during wound healing, demonstrating the restoration of the normal repair process by COL17 overexpression in diabetic wounds. Notably, we identified a key transcriptional signaling pathway for COL17, wherein pyruvate kinase isozyme M2 (PKM2) promotes phosphorylation of STAT3, leading to its activation and subsequent induction of COL17 expression upon injury. Ultimately, by manipulating this pathway using the PKM2 nuclear translocator SAICAR, we revealed a promising therapeutic strategy for enhancing the healing of chronic wounds.

Authors

Yangdan Liu, Chiakang Ho, Dongsheng Wen, Jiaming Sun, Yuxin Liu, Qingfeng Li, Yifan Zhang, Ya Gao

×

Figure 4

STAT3 promotes COL17A1 transcription and keratinocyte activation.

Options: View larger image (or click on image) Download as PowerPoint
STAT3 promotes COL17A1 transcription and keratinocyte activation.
(A) DN...
(A) DNA pull-down plus LC-MS/MS upregulated protein assay results with AnimalTFDB v4.0 data and JASPAR prediction. (B) ChIP analysis of STAT3 enrichment at the Col17a1 promoter in murine wound edge tissues on PWD 0 and 5. (C) Luciferase reporter assay of COL17 transcriptional activity with or without STAT3 transfection. (D) Chronological protein expression levels of phosphorylated and total STAT3 in wound edge tissues from PWD 0 to 7. (E) Western blot and quantification of COL17 and phosphorylated and total STAT3 in HaCaT cells treated with different concentrations of S3I-201. (F) Wound-healing assay and quantification analysis of HaCaT cells treated with different concentrations of S3I-201 (scale bar: 100 μm). (G) EdU (green) proliferation assay and quantification analysis of HaCaT cells treated with different concentrations of S3I-201 (scale bar: 100 μm). (H) Adhesion assay and quantification analysis of HaCaT cells treated with different concentrations of S3I-201. The in vitro data are presented as the mean ± SEM (n = 3 independent experiments). **P < 0.01, ***P < 0.001. ANOVA with Tukey’s test was used to compare multiple groups.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts